Carsatrin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCarsatrin
Drug Alias NameRWJ-24517RWJ-25319RWJ-25320
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel antagonistsSodium channels stimulants
TargetsSodium channelsPotassium channel
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A